Skip to main content
. 2018 May 30;72(6):832–840. doi: 10.1038/s41430-018-0174-2

Table 2.

Long-chain n-3 polyunsaturated fatty acid composition (µmol/L) of plasma phosphatidylcholine at before and after 14 days of consuming the oil supplement

Intake (g/d) n Eicosapentaenoic acid (µmol/L) Docosapentaenoic acid (µmol/L) Docosahexaenoic acid (µmol/L)
EPA DHA EPA+DHA Day 0a Day 14a Differenceb Day 0c Day 14a Differenceb Day 0a Day 14a Differenceb
0.19 0.14 0.33 15 43 (19) 72 (51) 29 (−15, 72) 31 (10) 43 (32) 12 (−11, 34) 144 (92) 180 (167) 37 (−89, 163)
0.38 0.28 0.66 12 41 (10) 122 (55) 81 (37, 125)c 29 (8) 49 (24) 20 (3, 37)c 151 (75) 198 (68) 47 (−2, 96)
0.44 0.28 0.72 19 42 (22) 78 (45) 36 (6, 65)c 31 (15) 45 (24) 13 (0, 27)c 157 (92) 177 (105) 20 (−61, 101)
0.55 0.42 0.99 12 54 (36) 168 (79) 113 (62, 164)c 35 (20) 53 (24) 18 (5, 32)c 147 (80) 227 (88) 80 (28, 132)c
0.76 0.56 1.32 1 32 (11) 147 (67) 115 (58, 171)c 27 (8) 48 (20) 21 (4, 39)c 121 (42) 193 (90) 72 (−3, 148)
0.88 0.56 1.44 13 53 (29) 106 (43) 52 (10, 94)c 39 (19) 43 (9) 3 (−13, 19) 201 (131) 186 (30) −15 (−123, 93)
0.95 0.55 1.50 47 39 (23) 136 (60) 97 (75, 119)c 29 (14) 42 (19) 13 (7, 19)c 126 (57) 168 (75) 42 (17, 66)c
0.95 0.70 1.65 7 54 (38) 174 (40) 120 (66, 173)c 29 (9) 42 (9) 12 (3, 22)c 141 (38) 184 (32) 43 (14, 72)c
1.32 0.84 2.16 10 43 (36) 117 (37) 74 (17, 130)c 32 (11) 42 (12) 10 (−3, 23) 148 (71) 176 (65) 28 (−73, 129)
1.90 1.10 3.00 48 38 (18) 200 (88) 162 (128, 196)c 29 (12) 49 (19) 21 (13, 28)c 129 (50) 185 (70) 56 (36, 76)c
1.90 1.40 3.30 8 56 (32) 284 (124) 228 (88, 367)c 42 (8) 74 (29) 32 (2, 62)c 175 (60) 274 (114) 98 (−16, 213)
2.20 1.40 3.60 12 45 (23) 229 (145) 183 (61, 305)c 32 (12) 72 (32) 40 (14, 66)c 133 (44) 282 (135) 149 (48, 250)c
2.85 1.65 4.50 10 36 (15) 298 (138) 262 (121, 403)c 28 (11) 74 (31) 46 (15, 77)c 143 (62) 272 (106) 129 (37, 221)c

a Values are mean (SD)

b Values are mean (99% CI)

c Day 14 significantly different from day 0, paired t-test P < 0.01